See also this year's filing and all EDGAR filings for this company.
PDF Report 0001492422_2021_Apellis_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001492422, Apellis Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 917,192,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,803,000 |
| 3 | remainder_Assets | 36,574,000 |
| 4 | LiabilitiesCurrent | 128,327,000 |
| 5 | LiabilitiesNoncurrent | 15,217,000 |
| 6 | remainder_Liabilities | 612,468,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 139,401,000 |
| 9 | ResearchAndDevelopmentExpense | 299,921,000 |
| 10 | remainder_Expenses | 56,832,000 |
| 11 | remainder_Revenues | 250,646,000 |
| 12 | remainder_NetIncome | -99,366,000 |
| 13 | remainder_ComprehensiveNetIncome | 37,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 960,569,000 |
| 1 | Liabilities | 756,012,000 |
| 2 | Expenses | 496,154,000 |
| 3 | Revenues | 250,646,000 |
| 4 | StockholdersEquity | 204,557,000 |
| 5 | NetIncome | -344,874,000 |
| 6 | ComprehensiveNetIncome | -344,855,500 |
| 7 | BaseVar | 1,281,392,000 |
| 8 | EconomicCapitalRatio | 0.00814 |
Edgar->Model Mapping
Feature Distribution
Change over Time
